Digital Health Solutions for Patients With Type 2 Diabetes

Enrolling by invitation · Not applicable

Conditions studied: Diabetes Mellitus Type 2

In brief

We will conduct a prospective, single-center observational study involving 60 adult T2D patients recruited from Chang Gung Memorial Hospital. Participants will be randomly allocated to either a CGM group or a control group receiving standard care. The intervention group will utilize mobile apps for medication tracking, and a remote communication platform. All participants will collect clinical data-including HbA1c, Time in Range (TIR), insulin use-at baseline and 12 weeks. Patient adherence and satisfaction with CGM will also be assessed.

Key facts

Study ID

NCT07642830

Run by

Chang Gung Memorial Hospital

People needed

60

Starts

2026-05-28

Expected to finish

2027-01-04

Last updated by the study team

2026-06-11

Who can join

Age: 20 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with confirmed diagnosis of T2D for >1 year, capable of using a smartphone, and willing to sign informed consent.

You may not qualify if…

• Patients with severe cardiac, hepatic, or renal disease; pregnant women; those participating in other experimental treatments; or unable to follow up.

Where it is running

• Chang Gung Memorial Hospital — Taoyuan, Taiwan, Taiwan

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.